Enrolling by Invitation
Immunologic and Virologic Parameters During Analytical Treatment Interruption Following Combination bNAb Therapy During Suppressive ART
NCT06908083
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Rockefeller Institute New York, United States